When management rejected T/O over offer, I understand they said it is worth 0.15 . Could this be the reason? Any thoughts?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025